Skip to main navigation Skip to search Skip to main content

FeOOH@Metal–Organic Framework Core–Satellite Nanocomposites for the Serum Metabolic Fingerprinting of Gynecological Cancers

  • Congcong Pei
  • , Chao Liu
  • , You Wang
  • , Dan Cheng
  • , Rongxin Li
  • , Weikang Shu
  • , Chaoqi Zhang
  • , Wenli Hu
  • , Aihua Jin
  • , Yannan Yang
  • , Jingjing Wan*
  • *Corresponding author for this work
  • East China Normal University
  • Shanghai Jiao Tong University
  • University of Queensland

Research output: Contribution to journal › Article › peer-review

Abstract

High-throughput metabolic analysis is of significance in diagnostics, while tedious sample pretreatment has largely hindered its clinic application. Herein, we designed FeOOH@ZIF-8 composites with enhanced ionization efficiency and size-exclusion effect for laser desorption/ionization mass spectrometry (LDI-MS)-based metabolic diagnosis of gynecological cancers. The FeOOH@ZIF-8-assisted LDI-MS achieved rapid, sensitive, and selective metabolic fingerprints of the native serum without any enrichment or purification. Further analysis of extracted serum metabolic fingerprints successfully discriminated patients with gynecological cancers (GCs) from healthy controls and also differentiated three major subtypes of GCs. Given the low cost, high-throughput, and easy operation, our approach brings a new dimension to disease analysis and classification.

Original languageEnglish
Pages (from-to)10831-10835
Number of pages5
JournalAngewandte Chemie - International Edition
Volume59
Issue number27
DOIs
StatePublished - 26 Jun 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • diagnostics
  • gynecological cancers
  • mass spectrometry
  • metabolites
  • metal–organic frameworks

Fingerprint

Dive into the research topics of 'FeOOH@Metal–Organic Framework Core–Satellite Nanocomposites for the Serum Metabolic Fingerprinting of Gynecological Cancers'. Together they form a unique fingerprint.

Cite this